Cargando…
THU331 Glycemic Variability In Critically Ill Sepsis Patients Comorbid With COVID-19: Relative Impact Of Diabetes And/Or Obesity
Disclosure: J. Rebernigg: None. K. Baez: None. N. Torres Rivera: None. B. Contreras: None. S. Yenari: None. K. Hamad: None. W. Wiese-Rometsch: None. V. Farhangi: None. •While certain endocrinopathies are known to increase dysglycemia in critically ill patients with sepsis or COVID-19, the impact on...
Autores principales: | June Rebernigg, Janevi, Baez, Karla, Torres Rivera, Nicole, Contreras, Berkis, Yenari, Sage, Hamad, Karen, Wiese-Rometsch, Wilhelmine, Farhangi, Vida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553389/ http://dx.doi.org/10.1210/jendso/bvad114.765 |
Ejemplares similares
-
THU332 Composite Glucose And Albumin Biomarker Tool Provides Strong Mortality Risk Assessment At Presentation And Throughout Index COVID-19 Hospitalization
por: Torres Rivera, Nicole, et al.
Publicado: (2023) -
THU318 Endocrine Phenotype Drives Mortality Risk At Presentation During Index Hospitalization With SARS-CoV-2 Infection: Differential Trait Signatures May Shed Some Light
por: Baez, Karla, et al.
Publicado: (2023) -
PSUN146 Diabetes, Obesity, and Diabetes-Obesity Overlap Syndrome in Hospitalized Adult COVID-19 Patients: Comorbidity Dose is The Thing!
por: Rodriguez, Karla Baez, et al.
Publicado: (2022) -
In-Hospital Glycemic Dysregulation Associated With Worse Outcomes in COVID-19
por: Rodriguez, Lisette Patricia, et al.
Publicado: (2021) -
Alpelisib-Induced Diabetic Ketoacidosis- A Case Report
por: Rodriguez, Lisette Patricia, et al.
Publicado: (2021)